LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 51.55 | 771.67 | 2568 | 6829 | 0.3760 | 0.4655 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 771.67 | 3254 | 7256 | 0.4484 | 0.5606 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 771.67 | 2665 | 7256 | 0.3673 | 0.4672 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 53.77 | 771.67 | 2747 | 7256 | 0.3786 | 0.4810 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.99 | 771.67 | 3584 | 7690 | 0.4661 | 0.5888 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.99 | 771.67 | 2908 | 7690 | 0.3782 | 0.4918 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 55.99 | 771.67 | 2912 | 7690 | 0.3787 | 0.4924 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 771.67 | 3815 | 8085 | 0.4718 | 0.6024 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 771.67 | 3146 | 8085 | 0.3891 | 0.5138 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 771.67 | 3188 | 8085 | 0.3943 | 0.5198 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.44 | 771.67 | 3966 | 8530 | 0.4649 | 0.6035 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.44 | 771.67 | 3366 | 8530 | 0.3946 | 0.5294 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.44 | 771.67 | 3324 | 8530 | 0.3897 | 0.5239 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 62.66 | 771.67 | 4185 | 8978 | 0.4661 | 0.6121 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 62.66 | 771.67 | 3658 | 8978 | 0.4074 | 0.5520 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 62.66 | 771.67 | 3581 | 8978 | 0.3988 | 0.5427 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.88 | 771.67 | 4470 | 9447 | 0.4732 | 0.6259 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.88 | 771.67 | 3886 | 9447 | 0.4113 | 0.5641 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 64.88 | 771.67 | 3683 | 9447 | 0.3899 | 0.5411 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.10 | 771.67 | 4894 | 9800 | 0.4994 | 0.6550 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.10 | 771.67 | 4188 | 9800 | 0.4273 | 0.5861 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.10 | 771.67 | 4043 | 9800 | 0.4125 | 0.5709 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.32 | 771.67 | 5136 | 10212 | 0.5029 | 0.6631 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.32 | 771.67 | 4398 | 10212 | 0.4307 | 0.5953 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.32 | 771.67 | 4184 | 10212 | 0.4097 | 0.5741 | MN20160304_L01 | N05 |